Labshake search
Citations for Tocris :
1 - 43 of 43 citations for Scyliorhinin I amide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... PKI14,22 amide (Tocris) 1μM ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 µM PKA inhibitor fragment (6-22) amide (Tocris Bioscience), 0.5 mM anisomycin (stock solution in EtOH ...
-
bioRxiv - Biochemistry 2024Quote: ... Exendin-3 (9-39) amide (2081) was purchased from Tocris. Recombinant GDF15 (957-GD ...
-
bioRxiv - Cell Biology 2020Quote: PKA inhibitor (PKI) fragment (6-22) amide was purchased from Tocris (Cat. No. 1904). Full length mouse PKIα was synthesized from L amino acids and then purified with High-performance liquid chromatography (HPLC ...
-
bioRxiv - Physiology 2024Quote: ... 4-(3-chloro-pyridin-2-yl)-piperazine-1-carboxylic acid (4-tert-butyl-phenyl)-amide (BCTC, Tocris #3875) 10 mM in DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... n=20) group were randomized to receive either saline or GLP-1R antagonist Exendin-3(9-39)amide (Ex-9) (Tocris Bioscience, UK) (85 μg/kg dissolved in saline ...
-
bioRxiv - Neuroscience 2020Quote: ... GF 109203X (Bisindoylmaleimide I, BIM I) and AIM-100 were from Tocris-Cookson ...
-
bioRxiv - Cancer Biology 2020Quote: ... 0.01µM Gastrin I (TOCRIS 3006), 0.1µg/mL Noggin (Peprotech 250-38) ...
-
bioRxiv - Physiology 2023Quote: ... an [Ca2+]i chelator (Tocris); NiCl2 hexahydrate ...
-
bioRxiv - Cell Biology 2024Quote: ... 0.25μM Sant-I (Tocris-#1974), 2μM Retinoic Acid (Sigma-#R2625) ...
-
Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumorsbioRxiv - Cancer Biology 2020Quote: ... 0.01 μM Gastrin I (TOCRIS 3006), 0.1 μg/mL Noggin (Peprotech 250-38) ...
-
bioRxiv - Cell Biology 2021Quote: ... a Rac1-inhibitor (Rac1-i; No2161, Tocris). To inhibit Dock release from Elmo ...
-
bioRxiv - Cancer Biology 2023Quote: ... hGastrin I 0.01μM (Tocris Bioscience, Cat# 3006), N-acetylcysteine 1.25mM (Sigma-Aldrich ...
-
bioRxiv - Developmental Biology 2020Quote: ... and TGFβ Receptor I Inhibitor II (25nM; Tocris were also used in this study ...
-
bioRxiv - Cancer Biology 2020Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 μM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Cancer Biology 2022Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were treated with 330nM Torin I (# 4247, Tocris) for 1 hour ...
-
bioRxiv - Neuroscience 2023Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 µM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris #I-440-01M) and mounted in modified rose chambers ...
-
bioRxiv - Neuroscience 2020Quote: ... or Eeyarestatin I (10 μM, TOCRIS, Bio-Techne GmbH, 3922). Both compounds were pre-diluted in DMSO (Sigma-Aldrich D2650) ...
-
bioRxiv - Bioengineering 2019Quote: ... TGF-β type I receptor inhibitor A83-01 500nM (Tocris), P38 inhibitor SB202190 10μM(Sigma-Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 500 nM TGF-b type I receptor inhibitor A83-01 (Tocris), 10 µM P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.5 μM TGFb type I Receptor inhibitor A83-01 (Tocris #2939). In addition ...
-
bioRxiv - Cancer Biology 2023Quote: ... hGastrin I (final concentration, 0.01 μmol/L) (Tocris Bioscience, Bristol, UK), N-acetylcysteine (final concentration ...
-
bioRxiv - Cancer Biology 2021Quote: ... 0.5 μM TGF-b type I receptor inhibitor A83-01 (Tocris Bioscience) and 1μM PGE2 (Tocris Bioscience) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5000 nM TGF-b type I receptor inhibitor A83-01 (Tocris #2939), 10 nM Prostaglandin E2 (Tocris #2296) ...
-
bioRxiv - Developmental Biology 2021Quote: ... GANT61, a Gli1/2 inhibitor (Gli-I, #3191) was purchased from Tocris Bioscience (Bio-Techne ...
-
bioRxiv - Immunology 2020Quote: ... 1 mM PMSF) supplemented with protease inhibitors (Protease Inhibitor Cocktail I, Tocris). Homogenates were centrifuged at 5000 g for 15 min at 4°C and supernatants were collected.
-
bioRxiv - Molecular Biology 2022Quote: ... MED14 depletion was combined with treatment with I-BET 151 dihydrochloride (Tocris, 4650), a BET bromodomain inhibitor ...
-
bioRxiv - Developmental Biology 2021Quote: ... The following inhibitors were used: Jak2/Stat3 inhibitor (Cucurbitacin I, 100 nM, Tocris), Jak2 inhibitor (Fedratinib ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Cat# 4126, Tocris), 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were pre-treated for 6 hours with 100 μM CPYPP (DOCK-i; No4568, Tocris). To inhibit Shh signaling ...
-
bioRxiv - Developmental Biology 2022Quote: ... the base media is supplemented with 1uM of BMP-I inhibitor (LDN-193189) (Tocris, # 6053), 5uM of GSK3-Inhibitor (CHIR99021 ...
-
bioRxiv - Cell Biology 2024Quote: ... Day 6: The medium was changed with the differentiation medium containing 0.25μM Sant-I (Tocris-#1974), 100ng/mL Noggin (Sino Biological-#10267) ...
-
bioRxiv - Neuroscience 2022Quote: ... To monitor acute changes in [Cl-]i we bath applied GABAA receptor agonist muscimol (Tocris, 10 μM) and imaged at lower resolution (every 2 minutes at a resolution of 4.1 pixels/μm (512×512 pixels ...
-
bioRxiv - Neuroscience 2019Quote: ... (9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester (K252a, 200 nM) (Tocris), 7,8-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one (DHF ...
-
bioRxiv - Neuroscience 2022Quote: ... LY 333531 (ruboxistaurin, 4738), sumanirole maleate (2773), GF 109203X (BIM I), and (RS)-3,5-dihydroxyphenylglycine (DHPG, 0342) were from Tocris. (S,S)-CE-158 was synthesized as previously described56 ...
-
bioRxiv - Neuroscience 2021Quote: ... To interfere with group I metabotropic glutamate receptor (mGluR) signaling we used bath application of either the mGlu1 receptor antagonist YM298198 (1 μM, Tocris, Germany) or the mGluR5 receptor antagonist MPEP (10 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of GABA (Tocris Bioscience, 100 μM) via a patch pipette placed in the vicinity of the cell soma and connected to a picospritzer (5–10 psi for 20– 40 ms ...
-
bioRxiv - Neuroscience 2021Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of either GABA (Tocris Bioscience, 100 μM) or glycine (Tocris Bioscience ...